Alliance for Lupus Research - ALR: Target Identification in Lupus (TIL) grants

Letter of intent. The ALR funds research that will accelerate the development of new treatments for lupus. As such, grant proposals should be innovative in direction and utilize state-of-the-art techniques. Fundamental studies must be oriented towards the development of drugs that would prevent and/or ameliorate clinical signs and symptoms of lupus. Funding: $400K over 2 years with an opportunity to apply for continued funding of up to $200K.